Healthpeak Properties officer proposes $127K share sale

The securities information lists restricted stock lapse as the acquisition transaction and equity compensation as the nature of payment.

Available on EDGAR 11/09/2026 - 04:54 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:54 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Healthpeak Properties, Inc. (DOC) officer Ankit B. Patadia reported a proposed sale of 6,115 common shares, with an aggregate market value of $127,041.00 and an approximate sale date of November 9, 2026. The shares were acquired through restricted stock lapse, with equity compensation listed as the nature of payment; the notice says they were acquired and paid for between February 12, 2022, and February 14, 2023.

Key Figures

Common shares proposed for sale: 6,115 shares Aggregate market value: $127,041.00 Shares outstanding: 689,543,752 shares +1 more

4 metrics

Common shares proposed for sale 6,115 shares Approximate sale date: November 9, 2026

Aggregate market value $127,041.00 Proposed sale

Shares outstanding 689,543,752 shares Listed in the securities information

Approximate date of sale November 9, 2026 Proposed sale

Key Terms

Restricted Stock Lapse, Aggregate Market Value, Equity Compensation

3 terms

Restricted Stock Lapse financial

"Restricted Stock Lapse - See Remarks"

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Equity Compensation financial

"Nature of Payment: Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DOC shares is Ankit B. Patadia proposing to sell?

Ankit B. Patadia, an officer, reported a proposed sale of 6,115 Healthpeak common shares with an aggregate market value of $127,041.00. The approximate sale date is November 9, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001963756
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HEALTHPEAK PROPERTIES, INC.
SEC File Number	001-08895
Address of Issuer	4600 SOUTH SYRACUSE STREET SUITE 500 DENVER COLORADO 80237
Phone	949-407-0700
Name of Person for Whose Account the Securities are To Be Sold	Patadia Ankit B.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	6115	127041.00	689543752	11/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2022	Restricted Stock Lapse - See Remarks	HEALTHPEAK PROPERTIES, INC.			6115	02/12/2022	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares on this filing were acquired and paid for from 02/12/2022 through 02/14/2023.
Date of Notice	11/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ankit B. Patadia
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)